Lutetium-177-PSMA Therapy for Recurrent/Metastatic Salivary Gland Cancer: A Phase 2 Pilot Study
Year: 2024
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4725315
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4392114021
